// App-Quantinova.ai

: Efficacy and Safety of Azacytidine Combined with Low-Dose Lenalidomide in Preemptive Treatment of Post Allo-SCT Acute Myeloid Leukemia Patients with Detectable Minimal Residual Disease

Researchers

Presenter

  • Lu Wang

Principal Investigators

  • Yimei Feng

  • Lei Gao

  • Peiyan Kong

  • Xi Zhang

Medical Centers

  • Medical Center of Hematology, Xinqiao Hospital, State Key Laboratory of Trauma, Burn and Combined Injury, Army Medical University, Chongqing, China, Chongqing, China

  • Medical center of hematology, Xinqiao Hospital, Army Medical University, Chongqing, Chongqing, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Oncology (ONC)

Disease

  • Graft-versus-host disease

  • Acute myelocytic leukemia

Biomarkers

  • N/A

Drug/Treatment

  • Lenalidomide

  • Vidaza

  • Allopurinol

Outcome

  • N/A

Study Design

  • Efficacy

  • Safety

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved